Vcanbio Cell & Gene Engineering Corp., Ltd (SHA:600645)
China flag China · Delayed Price · Currency is CNY
16.20
-0.28 (-1.70%)
Nov 17, 2026, 3:00 PM CST

SHA:600645 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
112.54113.83100.35106.45112.99155.32
Depreciation & Amortization
130.69130.69141.97143.6138.21124.62
Other Amortization
34.2734.2728.129.0226.1223.09
Loss (Gain) From Sale of Assets
-6.41-6.41-1.3-3.67-2.03-1.49
Asset Writedown & Restructuring Costs
1.341.344.680.310.827.64
Loss (Gain) From Sale of Investments
7.927.9244.3347.948.71-85.87
Provision & Write-off of Bad Debts
21.9321.9327.6820.917.6338.21
Other Operating Activities
-18.520.93.122.09-2.04-5.18
Change in Accounts Receivable
-20.2-20.2-31.23-12.23-31.9330.73
Change in Inventory
-7.36-7.36-0.63-9.25-27.64-4.56
Change in Accounts Payable
-3.37-3.37-11.18-1.0735.0619.42
Change in Other Net Operating Assets
---0.0312.21-6.68-19.46
Operating Cash Flow
292.92313.63285.19299.02261.89320.96
Operating Cash Flow Growth
-11.42%9.97%-4.62%14.18%-18.40%31.35%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-41.44-49.56-67.32-88.61-99.19-127.74
Sale of Property, Plant & Equipment
0.050.310.780.191.4212.63
Investment in Securities
-82.38-710.331.95-2.06-0.57-18.95
Other Investing Activities
9.7311.740.72---
Investing Cash Flow
-114.04-747.85-63.86-90.49-98.34-134.05

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Repaid
--65.04-41.19-35.76-41.33-29.13
Lease Payments
-65.04-65.04-25.42-29.45-35.02-22.82
Net Debt Issued (Repaid)
-65.04-65.04-41.19-35.76-41.33-29.13
Repurchase of Common Stock
---200.03---
Common Dividends Paid
------1.61
Other Financing Activities
19.82-9.07-43.6917.0333.58-18.97
Financing Cash Flow
-45.21-74.1-284.91-18.73-7.75-49.71

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-22.44-9.257.310.2235.3-7.44
Net Cash Flow
111.24-517.56-56.28200.02191.1129.75

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
251.49264.07217.87210.4162.7193.22
Free Cash Flow Growth
-10.01%21.21%3.55%29.32%-15.79%26.59%
Free Cash Flow Margin
18.28%18.15%13.74%13.23%10.46%12.58%
Free Cash Flow Per Share
0.540.580.480.460.350.41
Levered Free Cash Flow
194.62195.78191.89164.65141.27197.98
Unlevered Free Cash Flow
196.64197.8195.03167.79143.78199.95
Free Cash Flow After Leases
186.45199.04192.45180.95127.68170.39

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
--0.590.921.27-
Cash Income Tax Paid
169.98159.44162.15170.94110.96116.78
Change in Working Capital
9.179.17-63.75-47.63-38.4944.62